Evidence map›Paper›PMID 41947412›Full record

ArticleGigaScience2026

NEXT-scASV: a Nextflow pipeline for allele-specific variant calling from single-cell RNA-seq data.

Andrey Shevtsov, Andrey Buyan, Vladimir Nozdrin, Pavel Akhtyamov, Alexey Stupnikov, Georgy Meshcheryakov, Ivan V Kulakovskiy, Yulia A Medvedeva

Abstract read
In one paragraph

Article in GigaScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andrey ShevtsovResearch Institute of Biotechnology, Russian Academy of Sciences, Moscow117312 Vavilova Street 7  Russia.ORCID 0009-0002-2737-6609
Andrey BuyanInstitute of Protein Research, Russian Academy of Sciences, Institutskaya 4142290Pushchino  Russia.ORCID 0000-0001-9105-4028
Vladimir NozdrinFaculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, MoscowLeninskie Gory 1119234  Russia.
Pavel AkhtyamovDepartment of Biomedical Physics, Moscow Center for Advanced Studies, Kulakova Street 20b1, Moscow123592  Russia.ORCID 0009-0008-0778-1352
Alexey StupnikovResearch Institute of Biotechnology, Russian Academy of Sciences, Moscow117312 Vavilova Street 7  Russia.ORCID 0000-0001-7605-410X
Georgy MeshcheryakovInstitute of Protein Research, Russian Academy of Sciences, Institutskaya 4142290Pushchino  Russia.
Ivan V KulakovskiyInstitute of Protein Research, Russian Academy of Sciences, Institutskaya 4142290Pushchino  Russia.ORCID 0000-0002-6554-8128
Yulia A MedvedevaResearch Institute of Biotechnology, Russian Academy of Sciences, Moscow117312 Vavilova Street 7  Russia.ORCID 0000-0002-7587-1666

Funding

MSHERF 075-15-2024-666MSHERF 075-15-2025-014MSHERF 125091010189-3
6 · The paper itself

Abstract

The rapid accumulation of single-cell sequencing data presents major computational challenges in reproducibility, scaling, and handling data characteristics such as sparsity and technical variations, which complicate even basic analyses. The next level of complexity is the allele-specific analysis, focused on identifying differential gene expression or regulation between homologous chromosomes by estimating the allelic imbalance of read counts at individual single-nucleotide variants. Here, we present NEXT-scASV, a scalable Nextflow pipeline for calling allele-specific variants (ASVs) from 5' single-cell RNA sequencing data. NEXT-scASV automates the entire process-from read alignment and quality control to variant calling and statistical evaluation of the allelic imbalance-within a containerized environment, ensuring reproducibility and ease of deployment across platforms. NEXT-scASV is able to perform de novo ASV detection from single-cell sequencing data without prior genotyping. Its modular design allows for massive parallelization, efficiently handling the scale of modern atlas-level studies. We validate NEXT-scASV on a dataset of 135,000 peripheral blood mononuclear cells from 57 donors, demonstrating that it processes large-scale data efficiently, completing analysis in a week on a cluster with one node and 100 threads. Crucially, the pipeline reliably identifies ASVs even in rare cell populations (e.g., gdT GZMBhi and memory B IGHMhi cells), which remains elusive for bulk analyses. We also successfully detect allele-specific regulation of long non-coding RNAs and other lowly expressed, cell type-specific genes. Genes linked to detected ASVs show a high concordance (80%) with previously reported eQTLs. This strong validation confirms that NEXT-scASV produces biologically relevant results, making it a powerful tool for uncovering allele-specific regulation in large-scale, complex single-cell studies.

Indexed as

AllelesComputational BiologyHigh-Throughput Nucleotide SequencingRNA-SeqSequence Analysis, RNASingle-Cell AnalysisSoftwareHumansPolymorphism, Single NucleotideReproducibility of ResultsSingle-Cell Gene Expression Analysisallele-specific variantscomputational pipelineNextflowregulatory variantssingle-cell RNA-seq

Identifiers

PMID41947412
PMCPMC13148397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.